VCYT

Veracyte, Inc.

About VCYT

Veracyte, Inc. is a genomic diagnostics company. The Company offers customized biomarker testing and analytical services. It offers a complete range of in vitro diagnostic (IVD) and companion diagnostic development services to biopharmaceutical companies and diagnostic companies. It offers tests across various diseases, which include Afirma Genomic Sequencing Classifier for thyroid cancer; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer; Prosigna Breast Cancer Assay for breast cancer; Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer; Envisia Genomic Classifier test for interstitial lung diseases; Decipher Bladder Genomic Classifier test for bladder cancer and Immunoscore Colon Cancer Test for colon cancer. It also offers Immunogram, a spatial molecular analysis and bioinformatics tool that integrates genomic, transcriptomic and proteomic data to help researchers understand the intricacies of the tumor immune microenvironment.

Buy US stocks in Australia starting with VCYT. Open an account and start investing today!

Market Capitalisation

$1.83B

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$26.26

Low today

$25.15

Open price

$0.00

52-week high

$33.23

52-week low

$14.85

VCYT FAQs

How much is one share of Veracyte, Inc.?

One share of Veracyte, Inc. is valued at $25.73.

What is the ticker symbol for Veracyte, Inc.?

The ticker symbol for Veracyte, Inc. is VCYT.

How do I buy VCYT shares in Australia?

To buy VCYT stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in VCYT

What is the market capitalisation of Veracyte, Inc. VCYT?

As of 07/02/2023 Veracyte, Inc. has a market cap of $1.8B.

What is the 52-week high for Veracyte, Inc. stock?

The Veracyte, Inc. 52-week high stock price is $33.23.

What is the 52-week low for Veracyte, Inc. stock?

The Veracyte, Inc. 52-week low stock price is $14.85.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.